NEW YORK (Reuters Health) – Patients who have undergone prior systemic therapies for cutaneous T-cell lymphoma may respond well to treatment with romidepsin, a potent inhibitor of histone…
NEW YORK (Reuters Health) – The response rate with standard treatment of hepatitis C infection is doubled when a hepatitis C virus (HCV) protease inhibitor, boceprevir, is added…
NEW YORK (Reuters Health) – In women undergoing in vitro fertilization, hormonal support with progesterone plus estradiol supplementation during the luteal phase after embryo transfer improves pregnancy and…
NEW YORK (Reuters Health) – There appears to be no increase or decrease in mortality among arthritis patients treated with anti-tumor necrosis factor agents, when compared to standard…
NEW YORK (Reuters Health) – Outcomes of percutaneous coronary intervention are just as good when a loading dose of clopidogrel is given in the cath lab just before…
NEW YORK (Reuters Health) – Cervical biopsies guided by colposcopy are accurate in confirming suspected cases of high-grade cervical intraepithelial neoplasia (CIN), but the negative predictive value is…
NEW YORK (Reuters Health) – A lower INR for low-risk anticoagulated patients with mechanical aortic valve replacement reduces the risk of bleeding without increasing the rate of thromboembolic…
NEW YORK (Reuters Health) – By spotting pregnant women at risk for preeclampsia and starting them on low-dose aspirin before 16 weeks’ gestation, physicians can more than halve…
NEW YORK (Reuters Health) – Prospective study results suggest that saquinavir is the only older protease inhibitor (PI) not associated with an increased risk of myocardial infarction (MI).…
NEW YORK (Reuters Health) – After ruling out an upper gastrointestinal (GI) source of bleeding, patients with serious hematochezia should undergo colonoscopy within the next few days. But…
